Status:

COMPLETED

Evaluation of a Portable Oxygen Concentrator During Ambulation for Patients Who Require Supplemental Oxygen (POC-LEAN)

Lead Sponsor:

ResMed

Conditions:

Chronic Obstructive Pulmonary Disease

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Prospective randomized study with a cross-over design. Mobi™ is a relatively new POC in the market and thus it is valuable to collect data from COPD patients using supplemental oxygen, and their use o...

Eligibility Criteria

Inclusion

  • Informed consent obtained before any study-related activities. Study-related activities are any procedures that are carried out as part of the study, including activities to determine suitability for the study.
  • Male or female, age ≥ 18 years at the time of signing informed consent.
  • Diagnosed with COPD and currently in a stable state (at least 4 weeks since last exacerbation episode22).
  • Current prescription for long-term oxygen therapy.
  • Participants meet the criteria for pulse-dose portable oxygen delivery, defined as being mobile within the home and the qualifying blood gas study was performed at rest/ awake or during exercise.
  • Participants who can read and comprehend English.

Exclusion

  • Clinically unstable, in the investigator's opinion, which might jeopardize the participant's safety or compliance with the protocol.
  • Current oxygen therapy prescription for \>5 L/min continuous flow.
  • Known or suspected contraindication for pulse-dose oxygen.
  • Unable to complete 6MWTs, e.g., unstable angina and myocardial infarction during the previous month
  • Female who is pregnant, breast-feeding, or intends to become pregnant, or is of child-bearing potential and not using an adequate contraceptive method (adequate contraceptive measure as required by local regulation or practice).

Key Trial Info

Start Date :

November 21 2019

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

March 9 2020

Estimated Enrollment :

33 Patients enrolled

Trial Details

Trial ID

NCT04107493

Start Date

November 21 2019

End Date

March 9 2020

Last Update

May 26 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

SleepData

San Diego, California, United States, 92123